Grégory Olszowy

Crédit Mutuel Asset Management SA (CM-AM) is an asset management firm headquartered in Paris, France. The firm was founded in 1992 and is a subsidiary of Groupe Crédit Mutuel Centre Est Europe SA, ultimately held by Confederation Nationale Crédit Mutuel SA. CM-AM offers a complete range of funds to various investors.

Tocqueville Finance SA is the asset management subsidiary of La Banque Postale SA, which is owned by La Poste SA in France. Headquartered in Paris, the firm was founded in 1991 and offers tailor-made investment solutions to private individual and institutional clients.

Finaltis SA is an alternative investment management firm headquartered in Paris, France. It was founded by Denis Beaudoin in 2001 and is a subsidiary of Finaltis SAS. The firm offers alternative investment solutions to institutional and private clients. Finaltis is a signatory of the United Nations Principles for Responsible Investment (UNPRI).

Spark Therapeutics Ireland Ltd. develops new gene medicines to treat autosomal dominant genetic diseases. Its product RhoNova, is designed for the treatment of patients with rhodopsin linked autosomal dominant retinitis pigmentosa, a debilitating, progressive form of inherited blindness resulting from a diverse array of mutations in the RHO gene. The company was founded by Jane G. Farrar, Paul Kenna, and Gearóid Tuohy and is headquartered in Dublin, Ireland.

Auris Gestion SA is an independent wealth management firm headquartered in Paris, France. The firm was founded as Auris Gestion Privée SA in 2004 by former managers and executives of Lombard Odier and Neuflize, Paribas and Rothschild. Auris Gestion provides discretionary management services, based on stock selection across asset classes, for individual and institutional clients such as private investors, business executives, families, artists, top athletes and associations.

Parvulus Suisse SA provides medical technology. It focused on commercializing devices for cardiac surgery distribution, manufacturing, sales and distribution. The company was founded in March 20011 and is headquartered in Lonay, Switzerland.

iM Global Partner SAS is a worldwide asset management network that selects and builds long-term partnerships with talented and independent asset management companies through direct capital ownership. The company is based in Paris, FR, and has subsidiaries in the United Kingdom, Luxembourg, Spain, the United States, and France. The French company provides its clients with access to the best management strategies of its partners through a wide range of investment solutions, including the Oyster range, a SICAV, mutual funds, and ETFs dedicated to US investors. iM Global Partner has an experienced business development team present in 10 locations across the world. The company was founded in 2012, and the CEO is Philippe Couvrecelle. The company represents around 35 billion USD of assets under management as of end July 2021. iM Global Partner was acquired by iM Square SAS from Cie Financière Jacques Coeur SAS.

FOURPOINTS Investment Managers SAS (FOURPOINTS) is an investment management subsidiary of Homa Capital SA in France. The firm was founded by Béatrice Philippe in 2012 when PIM Gestion France and IT Asset Management merged. Headquartered in Paris, FOURPOINTS offers investment solutions for retail, institutional and CGPI clients. It is available through a wide variety of management methods: management under mandate, managed management, equity funds and diversified funds of funds.

Part of Actinogen Medical Ltd., Corticrine Ltd. develops and manufactures drugs. The company is based in Edinburgh, UK. Corticrine was acquired by Actinogen Medical Ltd. on December 01, 2014 for $4.97 million.